Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.7K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.7K
Amyloid Fibrils03:03

Amyloid Fibrils

12.0K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
6.5K
Fibril-associated Collagen01:11

Fibril-associated Collagen

3.4K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Relative Risk01:12

Relative Risk

2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Transcription Factors02:16

Transcription Factors

82.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Private versus public hospital care after emergency admission for atrial fibrillation: a call for optimising atrial fibrillation care.

Heart (British Cardiac Society)·2026
Same author

Prognostic Value of ECG-derived f-wave Indices from Implantable Loop Recorder: Analysis from the LOOP Study.

Heart rhythm·2026
Same author

Prevention of depression in patients with atrial fibrillation using an online personalized intervention: The HOPE-AF feasibility study.

European journal of cardiovascular nursing·2026
Same author

Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Inflammation and day-to-day occurrence of atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

[Consumer wearables, cardiology and clinical practice].

Ugeskrift for laeger·2026

Related Experiment Video

Updated: Feb 8, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.8K

Risk Factor Management in Atrial Fibrillation.

Axel Brandes1, Marcelle D Smit2, Bao Oanh Nguyen2

  • 1Department of Cardiology, Cardiology Research Unit, Odense University Hospital, University of Southern Denmark Odense, Denmark.

Arrhythmia & Electrophysiology Review
|July 4, 2018
PubMed
Summary

Atrial fibrillation (AF) is a common arrhythmia linked to serious health issues. Managing modifiable risk factors and underlying conditions is key to improving AF outcomes and patient care.

Keywords:
Atrial fibrillationintegrated managementlifestyle modificationpreventionrisk factors

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.6K

Related Experiment Videos

Last Updated: Feb 8, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.8K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.6K

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Epidemiology

Background:

  • Atrial fibrillation (AF) is the most prevalent clinical arrhythmia, significantly increasing morbidity and mortality.
  • Evidence indicates that AF is rarely isolated, with numerous associated cardiovascular diseases and risk factors.
  • Current management often focuses on anticoagulation and rate/rhythm control, with less emphasis on risk factor modification.

Purpose of the Study:

  • To review the association between modifiable risk factors, underlying conditions, and the development/progression of AF.
  • To discuss the evidence supporting early management of underlying conditions for improved AF outcomes.
  • To provide insights into implementing tailored AF management strategies in clinical practice.

Main Methods:

  • Literature review of current evidence on AF and its associated risk factors.
  • Analysis of studies investigating the impact of managing underlying conditions on AF progression.
  • Synthesis of data to inform clinical practice guidelines.

Main Results:

  • Numerous modifiable cardiovascular risk factors and underlying conditions are strongly associated with incident AF.
  • Early and effective management of these conditions shows promise in improving AF outcomes.
  • A gap exists in the clinical implementation of comprehensive, risk-factor-targeted AF management.

Conclusions:

  • Addressing modifiable risk factors and underlying conditions is crucial for effective AF management.
  • Integrating risk factor modification into AF treatment strategies can enhance patient outcomes.
  • Tailored AF management plans are essential for optimizing care in daily clinical practice.